Kevin Tang - Jan 12, 2022 Form 4 Insider Report for LA JOLLA PHARMACEUTICAL CO (LJPC)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	LJPC	Stock Option (Right to Buy)	Award	$0	+30K		$0.00	30K	Jan 12, 2022	Common Stock	30K	$4.81	Direct	F1

Showing 1 to 1 of 1 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	The stock options vest and become exercisable on January 12, 2023, subject to the Reporting Person's continued service to the Issuer through such date.